VLN holder plans Rule 144 sale of 36,440 ordinary shares

VLN has a Form 144 notice for a planned sale of 36,440 ordinary shares, to be executed through Oppenheimer & Co. Inc. on the NYSE around 01/09/2026.

Accepted by SEC EDGAR 01/12/2026 - 07:51 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

VLN has a Form 144 notice for a planned sale of 36,440 ordinary shares, to be executed through Oppenheimer & Co. Inc. on the NYSE around 01/09/2026. The filing lists an aggregate market value of $56,846.40 for these shares and notes that 106,342,415 shares of this class are outstanding.

The shares to be sold were acquired through an employee stock option plan in two grants dated 09/02/2016 (33,127 shares) and 06/01/2017 (3,313 shares), with cash upon exercise scheduled for 01/09/2026. The person filing represents that they are not aware of undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the VLN Form 144 filing disclose?

The Form 144 discloses a planned sale of 36,440 ordinary shares of VLN, with an aggregate market value of $56,846.40, to be sold on the NYSE through Oppenheimer & Co. Inc. around 01/09/2026.

How many VLN shares are planned to be sold and at what value?

The filing lists 36,440 ordinary shares to be sold with an aggregate market value of $56,846.40.

How many VLN shares are outstanding for this class?

The Form 144 states that there are 106,342,415 ordinary shares of this class outstanding.

When were the VLN shares in this Form 144 originally acquired?

The shares were acquired through an employee stock option plan on 09/02/2016 for 33,127 shares and on 06/01/2017 for 3,313 shares.

How will the purchase price for the VLN shares be paid on exercise?

The Form 144 states that the options will be settled with cash upon exercise on 01/09/2026.

What representation does the seller make about VLN’s information in the Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about VLN’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002082855
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Valens Semiconductor Ltd.
SEC File Number	001-40842
Address of Issuer	8 HANAGAR ST. POB 7152 HOD HASHARON, 4501309 ISRAEL 00000
Phone	972-9-762-6900
Name of Person for Whose Account the Securities are To Be Sold	Boim Amir
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 broad st. New York NY 10004	36440	56846.40	106342415	01/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	09/02/2016	Employee Stock Options plan	Issuer			33127	01/09/2026	Cash Upon Exercise
Ordinary	06/01/2017	Employee Stock Options plan	Issuer			3313	01/09/2026	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 08-11-2025
Date of Notice	01/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Amir Boim
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)